SMC Healthcare Co. intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Health Care Equipment & Svc. Listed on Saudi Exchange Tadawul.
Specialized Medical Company owns and operates hospitals, clinics, and medical centers in Saudi Arabia through its Medical Services and Pharmacies and Others segments. Its facilities include surgical units, critical care units such as ICU and NICU, and diagnostic services including radiology and physiotherapy. The company was incorporated in 1994 and is headquartered in Riyadh.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 15.57 compared to a market price of SAR 16.15 (Trading near DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 13% over the three-year period, while net income grew at a considerably faster rate of approximately 58%, indicating that profitability increased faster than sales. Operating cash flow increased by about 38% overall, also outpacing revenue growth but at a slower rate than net income, after rising sharply in the second year and then easing somewhat in the third. Overall, the company's historical financial performance shows growth in revenue, net income, and operating cash flow, with profitability increasing the fastest of the three.
Dividend per share held steady at SAR 0.8 for 1 consecutive years before declining to SAR 0.32 in the most recent year, a decrease of about 60%. Payments have been made on an Annual basis throughout this period. Overall, the dividend held flat for most of the period before a recent decline. Current dividend yield is approximately 1.98%, with a payout ratio of approximately 30.05%.
TASIV's Competitive Advantage assessment for this company is High (79/100), based on profitability, predictability, financial strength, and growth resilience.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of SMC Healthcare Co. is approximately SAR 15.57, compared to a current market price of SAR 16.15. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, SMC Healthcare Co. is currently "Trading near DCF model value".
SMC Healthcare Co.'s dividend yield is approximately 1.98%, with a payout ratio of approximately 30.05%, based on TASIV's most recent verified data.
Loading 4019...